Cargando…

Editorial: Strengths and Challenges of Allo-SCT in the Modern Era

Detalles Bibliográficos
Autores principales:	Malagola, Michele, Greco, Raffaella, Peccatori, Jacopo, Isidori, Alessandro, Romee, Rizwan, Mohty, Mohamad, Ciceri, Fabio, Russo, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907534/ https://www.ncbi.nlm.nih.gov/pubmed/35280781 http://dx.doi.org/10.3389/fonc.2022.850403

Ejemplares similares

Outcomes of Allogeneic Stem Cell Transplant (allo-SCT) Recipients in the Era of Newer Antifungal Agents
por: Shah, Nishi, et al.
Publicado: (2014)

Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
por: Greco, Raffaella, et al.
Publicado: (2021)

Fatal H1N1 influenza infection in an allo-SCT recipient
por: Rozovski, U, et al.
Publicado: (2010)

P502: PHASE II STUDY ON VENETOCLAX PLUS DECITABINE FOR ELDERLY (≥60 <75YEARS) PATIENTS WITH NEWLY DIAGNOSED HIGH-INTERMEDIATE RISK AML ELEGIBLE FOR ALLO-SCT: MIDTERM UPDATE OF VEN-DEC GITMO STUDY
por: Russo, Domenico, et al.
Publicado: (2023)

Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center
por: Bensinger, W, et al.
Publicado: (2012)

What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?
por: Simon, Steffen T., et al.
Publicado: (2021)

Rapid Recovery from Chronic PRCA by MSC Infusion in Patient after Major ABO-Mismatched alloSCT
por: Sergeevicheva, Vera, et al.
Publicado: (2012)

NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML
por: Chretien, Anne-Sophie, et al.
Publicado: (2017)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT
por: Tran, Misha C., et al.
Publicado: (2022)

Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level
por: Uike, Naokuni, et al.
Publicado: (2011)

Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
por: Filippini Velázquez, Giuliano, et al.
Publicado: (2023)

Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis
por: Shen, Zhenglei, et al.
Publicado: (2018)

Editorial: Innate immune cell therapy of cancer
por: Khatwani, Natasha, et al.
Publicado: (2022)

The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era
por: Morello, Enrico, et al.
Publicado: (2018)

Innovative Platforms for Haploidentical Stem Cell Transplantation: The Role of Unmanipulated Donor Graft
por: Ciceri, Fabio, et al.
Publicado: (2011)

Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC)
por: Bregni, Marco, et al.
Publicado: (2011)

Hematopoietic SCT in Europe: data and trends in 2011
por: Passweg, J R, et al.
Publicado: (2013)

SCT Barrel
por: Marcelloni Oliveira, C
Publicado: (2005)

SCT barrel
por: Marcelloni Oliveira, C
Publicado: (2005)

Commissioning of the SCT
por: Hayward, H
Publicado: (2008)

Editorial: Future challenges and directions in determining allo-immunity in kidney transplantation
por: Lim, Wai H., et al.
Publicado: (2022)

Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT – A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party
por: Penack, Olaf, et al.
Publicado: (2020)

Ultrasound elastography techniques for diagnosis and follow-up of hepatic veno-occlusive disease
por: Lazzari, Lorenzo, et al.
Publicado: (2019)

P371: PONATINIB AS A PROPHYLACTIC OR PRE-EMPTIVE STRATEGY TO PREVENT CYTOLOGICAL RELAPSE AFTER ALLO-SCT IN PATIENTS WITH PH POS ALL TRANSPLANTED IN COMPLETE CYTOLOGICAL REMISSION
por: Candoni, Anna, et al.
Publicado: (2023)

Redundancy and Synchronisation in the SCT
por: Nickerson, R B, et al.
Publicado: (1996)

Redundancy and Synchronisation in the SCT
por: Nickerson, R B, et al.
Publicado: (1996)

Status of the ATLAS SCT
por: Clark, Allan, et al.
Publicado: (2007)

ATLAS SCT Commissioning
por: Limper, Maaike
Publicado: (2007)

Allô France : méthode de français.
por: Leeman, Danielle
Publicado: (1985)

Allô France : méthode de français.
por: Leeman, Danielle
Publicado: (1987)

Allô France : méthode de français.
por: Leeman, Danielle
Publicado: (1987)

Editorial: Pulmonary Hypertension in the Modern Era: Science and Clinical Practice
por: Goncharova, Elena A., et al.
Publicado: (2021)

CMV Management with Specific Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted Patients
por: Malagola, Michele, et al.
Publicado: (2019)

The hatfield SCT lunar atlas: photographic atlas for Meade, Celestron and other SCT telescopes
por: Cook, Jeremy
Publicado: (2005)

The Hatfield SCT lunar atlas: photographic atlas for Meade, Celestron, and other SCT telescopes
por: Cook, Anthony
Publicado: (2014)

SCT - Semi-Conductor Tracker
por: Vanden Broeck, Renilde
Publicado: (2019)

Determination of SCT Wheel Positions
por: Haywood, S
Publicado: (2001)

Module Overlaps in the SCT and Pixels
por: Haywood, S
Publicado: (2002)

The ATLAS SCT Production Database
por: Clark, A, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_pe0p944tcd4j171krgg6kqaiaj